FGL2 and B-cell non-Hodgkin lymphoma: FGL2 activity increases in B-cell lymphomas but decreases after remission; moreover, detection of FGL2 activity in peripheral blood mononuclear cells (PBMCs) could be a biomarker for B-cell lymphomas14.